hydroxyurea has been researched along with Lymph Node Metastasis in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-five evaluable patients with stage IIIB carcinoma of the uterine cervix were entered into a prospective, double-blind, randomized study to evaluate the possible radiation-potentiating properties of hydroxyurea." | 5.06 | Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer. ( Emrich, LJ; Piver, MS; Vongtama, V, 1987) |
| "Thirty-three patients with malignant melanoma and regional lymph node metastases who underwent lymph node dissection were additionally given polychemotherapy with carmustine, hydroxycarbamide and dacarbazine immediately before surgery and up to five times postoperatively." | 5.06 | [Adjuvant chemotherapy in addition to radical surgical treatment of regional lymph node metastases in malignant melanoma]. ( Aragon, V; Bröcker, EB; Bünte, H; Czarnetzki, BM; Krieg, V; Macher, E, 1986) |
| "BCNU, hydroxyurea, and imidazole carboxamide (DTIC) were administered to 89 patients with disseminated malignant melanoma." | 3.65 | Combination chemotherapy for disseminated malignant melanoma. ( Coltman, CA; Costanzi, JJ; Delaney, FC; Hoogstraten, B; Quagliana, JM; Vaitkevicius, VK, 1975) |
| "Hydroxyurea was evaluated as a possible radiation sensitizer in 130 evaluable women with Stages IIB and IIIB (International Federation of Gynecology and Obstetrics) carcinoma of the uterine cervix." | 2.64 | Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix. ( Barlow, JJ; Blumenson, L; Piver, MS; Vongtama, V, 1977) |
| "Fifty-five patients with squamous cell carcinoma of the cervix uteri metastatic to high common iliac or periaortic lymph nodes underwent biopsy of the left scalene fat pad as part of a prospective clinical trial." | 1.27 | Biopsy of the scalene fat pad in carcinoma of the cervix uteri metastatic to the periaortic lymph nodes. ( Abdulhay, G; Bundy, BN; Fowler, WC; Hanjani, P; Stehman, FB; Whitney, CW, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (78.95) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, GX | 1 |
| Ding, XL | 1 |
| Wu, SB | 1 |
| Zhang, HF | 1 |
| Cao, W | 1 |
| Qu, LS | 1 |
| Zhang, H | 1 |
| Stehlin, JS | 1 |
| Hills, WJ | 1 |
| Rufino, C | 1 |
| Fine, BA | 1 |
| Hempling, RE | 1 |
| Piver, MS | 4 |
| Baker, TR | 1 |
| McAuley, M | 1 |
| Driscoll, D | 1 |
| Stehman, FB | 2 |
| Bundy, BN | 2 |
| Haie-Meder, C | 1 |
| Fervers, B | 1 |
| Chauvergne, J | 1 |
| Fondrinier, E | 1 |
| Lhommé, C | 1 |
| Guastalla, JP | 1 |
| Resbeut, M | 1 |
| Goldsmith, MA | 1 |
| Carter, SK | 1 |
| Barlow, JJ | 1 |
| Vongtama, V | 2 |
| Blumenson, L | 1 |
| Donelli, MG | 1 |
| Colombo, T | 1 |
| Broggini, M | 1 |
| Garattini, S | 1 |
| Brady, LW | 1 |
| Costanzi, JJ | 1 |
| Vaitkevicius, VK | 1 |
| Quagliana, JM | 1 |
| Hoogstraten, B | 1 |
| Coltman, CA | 1 |
| Delaney, FC | 1 |
| Emrich, LJ | 2 |
| Abdi, EA | 1 |
| Hanson, J | 1 |
| McPherson, TA | 1 |
| Hanjani, P | 1 |
| Fowler, WC | 1 |
| Abdulhay, G | 1 |
| Whitney, CW | 1 |
| Czarnetzki, BM | 1 |
| Aragon, V | 1 |
| Bröcker, EB | 1 |
| Krieg, V | 1 |
| Bünte, H | 1 |
| Macher, E | 1 |
| Krishnamsetty, RM | 1 |
| Seiji, M | 1 |
| Takahashi, M | 1 |
| Garin, AM | 1 |
| Lichinitser, MR | 1 |
| Moroz, LV | 1 |
| Scherer, E | 1 |
| Rassow, J | 1 |
| Sheiman, RA | 1 |
| Wayne, KS | 1 |
3 reviews available for hydroxyurea and Lymph Node Metastasis
| Article | Year |
|---|---|
[Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic | 1999 |
The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck.
Topics: Bleomycin; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Therapy, Combination; Fluoro | 1975 |
Combined modality therapy of gynecologic cancer.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Evaluation Studies as Topic; Female; Genit | 1975 |
4 trials available for hydroxyurea and Lymph Node Metastasis
| Article | Year |
|---|---|
Carcinoma of the cervix treated with chemotherapy and radiation therapy. Cooperative studies in the Gynecologic Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Clinical Trials as Topic; Combin | 1993 |
Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Hematopoiesis; Humans; Hydroxyurea; Lymphatic | 1977 |
Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer.
Topics: Adult; Aged; Carcinoma; Combined Modality Therapy; Female; Humans; Hydroxyurea; Lymphatic Metastasis | 1987 |
[Adjuvant chemotherapy in addition to radical surgical treatment of regional lymph node metastases in malignant melanoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Dacarbazine; | 1986 |
12 other studies available for hydroxyurea and Lymph Node Metastasis
| Article | Year |
|---|---|
Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Apoptosis; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cell Prolifer | 2015 |
Disseminated melanoma. Biologic behavior and treatment.
Topics: Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Dactinomycin; Fluorouracil; Humans; Hydrazine | 1967 |
Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Humans; Hyd | 1995 |
Differential distribution of antitumor agents in primary and secondary tumors.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma 256, Walker; Cyclophosphamide; Daunorubici | 1977 |
Combination chemotherapy for disseminated malignant melanoma.
Topics: Adolescent; Adult; Aged; Amides; Antineoplastic Agents; Brain Neoplasms; Carmustine; Drug Therapy, C | 1975 |
Adjuvant chemoimmunotherapy after regional lymphadenectomy for malignant melanoma.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carmustine; Com | 1987 |
Biopsy of the scalene fat pad in carcinoma of the cervix uteri metastatic to the periaortic lymph nodes.
Topics: Adipose Tissue; Adult; Aged; Aorta, Abdominal; Biopsy, Needle; Carcinoma, Squamous Cell; Cisplatin; | 1987 |
Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea.
Topics: Adult; Aged; Cesium Radioisotopes; Combined Modality Therapy; Female; Humans; Hydroxyurea; Lymphatic | 1985 |
Malignant melanoma with adjacent intraepidermal proliferation.
Topics: Adult; Chromomycin A3; Ethnicity; Female; Heel; Humans; Hydroxyurea; Lentigo; Lip Neoplasms; Lung Ne | 1974 |
[Imidazole carboxamide in the treatment of disseminated melanoblastoma].
Topics: Amides; Carmustine; Humans; Hydroxyurea; Imidazoles; Lymphatic Metastasis; Melanoma; Neoplasm Metast | 1973 |
[Basic principles of percutaneous radiotherapy in cervical lymph node metastases].
Topics: Carcinoma, Squamous Cell; Cesium Isotopes; Cobalt Isotopes; Electrons; Fluorouracil; Head and Neck N | 1971 |
Oral carcinoma and hypercalcemia.
Topics: Adult; Autopsy; Blood Chemical Analysis; Carcinoma, Squamous Cell; Cobalt Isotopes; Humans; Hydrocor | 1970 |